Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

545 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Collaboration between the Fab and Fc contribute to maximal protection against SARS-CoV-2 in nonhuman primates following NVX-CoV2373 subunit vaccine with Matrix-M™ vaccination.
Gorman MJ, Patel N, Guebre-Xabier M, Zhu A, Atyeo C, Pullen KM, Loos C, Goez-Gazi Y, Carrion R Jr, Tian JH, Yaun D, Bowman K, Zhou B, Maciejewski S, McGrath ME, Logue J, Frieman MB, Montefiori D, Mann C, Schendel S, Amanat F, Krammer F, Saphire EO, Lauffenburger D, Greene AM, Portnoff AD, Massare MJ, Ellingsworth L, Glenn G, Smith G, Alter G. Gorman MJ, et al. Among authors: krammer f. bioRxiv [Preprint]. 2021 Feb 5:2021.02.05.429759. doi: 10.1101/2021.02.05.429759. bioRxiv. 2021. Update in: Cell Rep Med. 2021 Sep 21;2(9):100405. doi: 10.1016/j.xcrm.2021.100405. PMID: 33564763 Free PMC article. Updated. Preprint.
SARS-CoV-2 Vaccines: Status Report.
Amanat F, Krammer F. Amanat F, et al. Among authors: krammer f. Immunity. 2020 Apr 14;52(4):583-589. doi: 10.1016/j.immuni.2020.03.007. Epub 2020 Apr 6. Immunity. 2020. PMID: 32259480 Free PMC article. Review.
Comparison of Transgenic and Adenovirus hACE2 Mouse Models for SARS-CoV-2 Infection.
Rathnasinghe R, Strohmeier S, Amanat F, Gillespie VL, Krammer F, García-Sastre A, Coughlan L, Schotsaert M, Uccellini M. Rathnasinghe R, et al. Among authors: krammer f. bioRxiv [Preprint]. 2020 Jul 6:2020.07.06.190066. doi: 10.1101/2020.07.06.190066. bioRxiv. 2020. Update in: Emerg Microbes Infect. 2020 Dec;9(1):2433-2445. doi: 10.1080/22221751.2020.1838955. PMID: 32676603 Free PMC article. Updated. Preprint.
Newcastle disease virus (NDV) expressing the spike protein of SARS-CoV-2 as vaccine candidate.
Sun W, Leist SR, McCroskery S, Liu Y, Slamanig S, Oliva J, Amanat F, Schäfer A, Dinnon KH, García-Sastre A, Krammer F, Baric RS, Palese P. Sun W, et al. Among authors: krammer f. bioRxiv [Preprint]. 2020 Jul 28:2020.07.26.221861. doi: 10.1101/2020.07.26.221861. bioRxiv. 2020. Update in: EBioMedicine. 2020 Dec;62:103132. doi: 10.1016/j.ebiom.2020.103132. PMID: 32743571 Free PMC article. Updated. Preprint.
A Newcastle disease virus (NDV) expressing membrane-anchored spike as a cost-effective inactivated SARS-CoV-2 vaccine.
Sun W, McCroskery S, Liu WC, Leist SR, Liu Y, Albrecht RA, Slamanig S, Oliva J, Amanat F, Schaefer A, Dinnon KH, Innis BL, Garcia-Sastre A, Krammer F, Baric RS, Palese P. Sun W, et al. Among authors: krammer f. bioRxiv [Preprint]. 2020 Jul 31:2020.07.30.229120. doi: 10.1101/2020.07.30.229120. bioRxiv. 2020. Update in: Vaccines (Basel). 2020 Dec 17;8(4):E771. doi: 10.3390/vaccines8040771. PMID: 32766572 Free PMC article. Updated. Preprint.
Introduction of two prolines and removal of the polybasic cleavage site leads to optimal efficacy of a recombinant spike based SARS-CoV-2 vaccine in the mouse model.
Amanat F, Strohmeier S, Rathnasinghe R, Schotsaert M, Coughlan L, García-Sastre A, Krammer F. Amanat F, et al. Among authors: krammer f. bioRxiv [Preprint]. 2020 Sep 17:2020.09.16.300970. doi: 10.1101/2020.09.16.300970. bioRxiv. 2020. Update in: mBio. 2021 Mar 2;12(2):e02648-20. doi: 10.1128/mBio.02648-20. PMID: 32995785 Free PMC article. Updated. Preprint.
545 results